FindTrial
Sign In

A randomized controlled study of 3C therapy and 4 daily insulin injections in patients with newly diagnosed type 2 diabetes mellitus hospitalized with severe hyperglycemia

A randomized controlled study of 3C therapy and 4 daily insulin injections in patients with newly diagnosed type 2 diabetes mellitus hospitalized with severe hyperglycemia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012660
Enrollment
Unknown
Registered
2017-09-13
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

3C:3C
Control group:MDI

Sponsors

Department of Endocrinology, Xinqiao Hospital,Third Military Medical University, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years old, men and women; 2. Newly diagnosed type 2 diabetes mellitus hospitalized with severe hyperglycemia; 3. No sugar treatment was taken before admission; 4. HbA1c>9% or fasting blood glucose >11.1mmol/L; 5. Be able to strictly abide by the procedures of this test and complete all test subjects.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or recent pregnant planners; 2. Combined with infectious and stress factors, acute complications such as diabetic ketosis, diabetic ketoacidosis, diabetic hyperosmolar state, etc.

Design outcomes

Primary

MeasureTime frame
blood glucose;—

Countries

China

Contacts

Public ContactYang Jing

Department of Endocrinology, Xinqiao Hospital,Third Military Medical University, Chongqing, China

yangjingnfm@163.com+86 13290077669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026